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Abstract
Introduction: Staphylococcus aureus is the major cause of bacteremia, with the potential for some
complications, namely mycotic aneurysms, defined as irreversible dilatation of an artery due to
destruction of the vessel wall by infection.
Case presentation: The authors present the case of a 52 year-old-Caucasian male, admitted with
Staphylococcus aureus bacteremia and mycotic aneurysm of the right superficial femoral artery,
associated with advanced atherosclerotic process.
Conclusion:  Mycotic aneurysms are rare, and a high index of suspicion is needed, because
appropriate treatment will certainly affect the outcome, as they are associated with high morbidity
and mortality.
Introduction
Staphylococcus aureus (SA) is the major cause of both com-
munity acquired and hospital acquired bacteremia and a
possible source of diverse complications, namely meta-
static seeding that can affect potentially any body site.
Methicillin-resistant strains are now responsible for over a
third of all staphylococcal bacteremias [1,2]. Humans are
a natural reservoir of SA and rates of colonization are high
among patients with type 1 diabetes, intravenous drug
users, hemodialysis, surgical patients and with HIV infec-
tion [3]. This microorganism constitutes in some series
the most common pathogen responsible for mycotic
aneurysms [4-7].
Mycotic aneurysms are defined as a localized, irreversible
dilatation of an artery due to destruction of the vessel wall
by infection [8], which can arise following an infection of
a previously healthy artery wall, or through secondary
infection of a preexisting aneurysm. Despite unusual,
mycotic aneurysms are seen more frequently in the femo-
ral artery and abdominal aorta, and less frequently in the
superior mesenteric, brachial, iliac and carotid arteries;
cerebral circulation may also be affected [5]. Mycotic
aneurysms are not exclusive of SA bacteremia and some
other microorganisms may be implicated: Salmonella,
Streptococcus pneumoniae, Mycobacterium tuberculosis and a
long list of fungi, gram negative and gram positive bacte-
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ria that have been reported less frequently. However, since
the introduction of antibiotics the bacteriology of infected
aneurysms has changed from Salmonella and Treponema
species to SA and gram negative bacilli [8].
There are a number of possible pathogenic mechanisms
implicated in the formation of a mycotic aneurysm: septic
emboli which occlude the vasa vasorum (frequently with
origin in bacterial endocarditis), contiguous infective
focus extending to the arterial wall, direct bacterial inocu-
lation or bacteremic seeding of an existing intimal injury
or atherosclerotic plaque [8,9].
Case presentation
The authors present the case of a 52-year-old-Caucasian
male, admitted to the emergency department in May 2007
with fever, polyarthralgia and peripheral edema, with
inflammatory signs in the back of the left foot. Six days
prior he had been discharged from the emergency depart-
ment with the diagnosis of erysipelas, medicated with lev-
ofloxacin. Blood cultures were drawn. As his complaints
persisted, he was readmitted and, because the blood cul-
tures were revealed positive for methicillin-resistant Sta-
phylococcus aureus (MRSA), he was admitted to an internal
medicine ward with the diagnosis of MRSA bacteremia.
About three weeks earlier, he had been hospitalized in a
Pneumology ward with the diagnosis of aggravated
chronic obstructive pulmonary disease. During the hospi-
tal stay he developed phlebitis with abscess of the right
arm at the site of an intravascular catheter. He was medi-
cated with flucloxacilin with resolution. One day after
being discharged he started fever.
In what refers to his past habits, he had an alcohol con-
sumption quantified in 60 grams/day and was a heavy
smoker - approximately 72 units of pack-years. In the last
8 years he had been a stoker, referring contact with black
dust, without any protection of the airways.
His past history was marked by bronchitis in childhood
and arterial hypertension; he referred two past episodes of
bronchopneumonia. He was medicated with perindopril
5 mg, aminophilin 225 mg, furosemide 40 mg and
inhaled bronchodilation therapy (tiotropium bromide
and fluticasone/salmeterol).
He had family history of type 2 diabetes mellitus, cere-
brovascular and coronary artery disease.
Blood tests on admission showed leukocytosis (16.5 G/L),
elevated C reactive protein (17.21 mg/dl, with normal
range < 0.5 mg/dl) and slight elevation of alanine ami-
notransferase (86 U/L, with normal range 10-40) and γ-
glutamyl-transferase (84 U/L, with normal range 11-49).
We started intravenous therapy with Trimethoprim-sul-
famethoxazole 960 mg twice daily, as the antibiogram
showed sensitivity for this antibiotic, and also for tetracy-
clines, rifampicin and glycopeptides. Initially, fever sub-
sided, but in the sixth day his condition worsened, with
fever and pain in his right thigh. Trimethoprim-sulfame-
thoxazole was suspended and he started intravenous van-
comycin 1 g twice daily. The following day he presented a
palpable, painful, non pulsatile mass with 3 cm in diam-
eter located in the internal aspect of his right thigh, with
edema, redness and heat; pedal pulse volume was dimin-
ished in his right limb; the ankle-brachial index was not
determined; a femoral bruit could be heard; there were
neither signs of hemorrhage nor clinical signs of carotid or
renal artery stenosis. An ultrasound demonstrated soft tis-
sue heterogeneity at the level of the superficial femoral
artery, in a sagittal extension of 8.9 cm, corresponding to
an atheromatous process of the artery associated with
inflammation. An occlusion of the superficial femoral
artery was detected by doppler and an angio-computed
tomography (CT), multislice with tridimensional recon-
struction demonstrated atheroma plaques in all arterial
vascular beds focused (Figure 1), with lumen reduction
above 70% in the medial third of the right superficial fem-
oral artery, with an aneurysmatic sacular formation down-
stream (1.6 × 1.3 cm of antero-posterior axis) (Figure 2);
a contiguous inflammatory process extending for 4 cm
was noted. Surgical treatment was postponed until septic
process was medically controlled. Rifampicin was added
while continuing vancomycin. Seven days later, as the ten-
derness of the right thigh persisted, the ultrasound was
repeated, showing an abscess with 11 cm in diameter,
CT scan Figure 1
CT scan. Atheroma plaques in all arterial vascular beds 
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with gas inside (Figure 3). The following day the patient
was submitted to surgical resection of a false mycotic
aneurysm of the right superficial femoral artery, with
placement of a femoro-femoral interposition graft of
reversed homolateral internal saphenous vein. Metroni-
dazole was started in association with vancomycin and
rifampicin; at day 4 metronidazole and rifampicin were
discontinued and replaced by imipenem because of a
cutaneous allergic reaction. After fifteen days of vancomy-
cin, creatinine started to rise (from basal value of 0.9 to
1.4 mg/dl, with normal range 0.7-1.3), and this antibiotic
was replaced with linezolid 600 mg twice daily, intrave-
nously.
The patient underwent trans-thoracic echocardiographic
study, which demonstrated fibrotic nodular thickening of
the subvalvular aspect of the mitral valve and calcification
of the head of the papillary muscles; a thickening of the
intimate-media complex was obvious in the thoracic
aorta, with multiple atheroma plaques, suggesting
advanced atherosclerotic process. Later on, trans-esopha-
geal echocardiogram was repeated with no evidence of
infectious vegetations. The labeled leukocyte scintigraphy
showed no other sites of accumulation besides the right
thigh. A thoraco-abdomino-pelvic angio CT demon-
strated calcified atheromatous plaques in the abdominal
aorta and iliac arteries, with no evidence of other aneurys-
matic formations (Figure 4).
In the twenty seventh day of admission, eighth day of imi-
penem and sixth day of linezolid, the fever completely
subsided and the patient showed favorable progress. The
only complication was a normocytic anemia in day 18 of
admission (Hemoglobin - 7.4 g/dl, with MCV of 86.6 fL),
with the need for packed red cells transfusion. Imipenem
was stopped after nine days and linezolid after 28 days.
He was discharged after 49 days to our outpatient clinic
for follow up; 9 days after being discharged he underwent
another transfusion for normocytic anemia (hemoglobin
of 7.6 g/dl, with MCV of 84.8 fL). The white blood cell and
the platelet counts remained unchanged; only red blood
cell count was affected. He maintained smoking habits
Mycotic aneurysm Figure 2
Mycotic aneurysm. CT scan with tridimensional recon-
struction showing an aneurysmatic sacular formation in the 
dependence of the right superficial femoral artery.
Ultrasound Figure 3
Ultrasound. Ultrasound showing an abscess with gas inside, 
located in the right thigh.
Abdominal CT scan Figure 4
Abdominal CT scan. An angio CT scan showed calcic 
atheromatous plaques in the abdominal aorta and iliac arter-
ies.Cases Journal 2009, 2:9386 http://www.casesjournal.com/content/2/1/9386
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and, in spite of some claudicating complains he keeps full
usage of his right limb.
Discussion
SA is the leading cause of bacteremia and is often associ-
ated with secondary metastatic complications. Our
patient had some risk factors for complications, namely
infection by MRSA, with persistence of fever for more than
72 hours after admission [10]. He had risk factors for col-
onization by MRSA: prior hospitalization and treatment
with antibiotics during his admission in a Pneumology
ward; the nares are the primary reservoir for staphyloco-
cci, and individuals with nasal carriage of MRSA will also
be colonized in areas of intact skin and other sites, for
example sputum; our patient had COPD, which is associ-
ated with hypertrophy and hyperplasia of the mucus-
secreting glands present in the epithelium of the airways,
consequently with increased sputum production. A diag-
nosis at admission of skin or soft tissue infection also
accounts as a risk factor for colonization; our patient had
a diagnosis of erysipelas at admission. Colonization is
associated with increased risk of subsequent MRSA infec-
tion with the same isolate [11,12].
Femoral aneurysms are often associated with percutane-
ous arterial access procedures or intravenous drug abuse
[6,9], none of these present in this case. Besides not hav-
ing history of arterial trauma, other risk factors that might
predispose for mycotic aneurysms weren't present: bacte-
rial endocarditis, local infection and impaired immunity
(diabetes, alcoholism, corticosteroids, chemotherapy,
malignancy and old age). The probable source of infec-
tion was the phlebitis associated with intravascular cathe-
ter during the prior admission. He had important
cardiovascular risk factors (heavy smoker, hypertension,
family history of type 2 diabetes), with advanced athero-
sclerotic process associated; the mechanism of infection
was, most likely, the bacterial seeding of atherosclerotic
plaques. Whether this was an infection of a previous aneu-
rysm or a primary infection of the arterial wall, with for-
mation of a new aneurysm we do not know.
The classic clinical presentation is that of a painful, pulsa-
tile, enlarged mass, in a patient with systemic symptoms
such as fever; hemorrhage or thrombosis can
occur[6,9,13]. Our patient had a painful, non pulsatile
mass, with inflammatory signs present and a local bruit;
he was febrile and there were no signs of hemorrhage. The
described signs are eventually masked by overlying
inflammation and mycotic aneurysms may be misdiag-
nosed. The diagnosis is confirmed by imaging studies
(ultrasound, computed tomography, angiography or
magnetic resonance angiography) and, sometimes,
mycotic aneurysms are only demonstrable in this way.
Infected aneurysms are often associated with radiographic
findings: the presence of air within the aneurysm, local
inflammation, contained rupture or saccular or lobulated
aneurysm [9]. In our patient the diagnosis was confirmed
by angio-CT scan multislice with tridimensional recon-
struction, which demonstrated a sacular formation, with a
contiguous inflammatory process. Systemic features of
inflammation and anemia are frequently present, and
blood cultures are positive in 50-85% of cases[4] On
admission our patient had elevated C reactive protein,
leukocytosis and positive blood cultures; anemia wasn't
present (hemoglobin - 14.5 g/dl).
Our patient was first treated with Trimethoprim-sulfame-
thoxazole, but after six days, as his condition worsened
and because this antibiotic usually has less intrinsic activ-
ity against staphylococci, we chose to start vancomycin
associated with rifampicin, with the goal of increasing
bactericidal activity. Surgical treatment was initially post-
poned, first because there were no signs of hemorrhage,
and second because primary repair isn't possible in
infected areas, as it is associated with more severe compli-
cations, such as graft infection or anastomotic dehiscence
[6,13,14]. However, despite medical treatment our
patient developed an abscess and was submitted to resec-
tion of the aneurysm and revascularization procedure in
day 16 of admission, without any further complications.
Anaerobic bacteria were probably involved in the abscess
formation, particularly with gas present; unfortunately,
the collected material wasn't sent for culture. Arterial liga-
tion with excision of the aneurysm, together with local
debridement of all necrotic tissue and drainage of associ-
ated abscess remains the first treatment step; revasculari-
zation at the time of the resection of the aneurysm offers
a better outcome for limb function and autogenous veins
are more resistant to infection [6,13,14]. After surgery,
broad spectrum antibiotics were started, with empiric cov-
erage of gram negative and anaerobic bacteria; although
admittedly empiric, some studies recommend 4-6 weeks
of parenteral antibiotic therapy, with extension of treat-
ment time if inflammatory biomarkers don't subside
[8,9]; our patient was treated for almost 50 days, with
complete resolution of the systemic features of inflamma-
tion. Linezolid replaced vancomycin (the patient devel-
oped acute renal failure), with good response, despite the
occurrence of anemia after being discharged, probably
due to linezolid therapy, as it can cause myelosuppres-
sion, related with the duration of treatment; in this case
red blood cell line was the only one affected.
Mycotic aneurysms are associated with high morbidity
and mortality rates, and combined therapy results in bet-
ter outcome [4,15].
Our patient was anticoagulated with subcutaneous enox-
aparin during admission, and then antiaggregated withPublish with BioMed Central    and   every 
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acetylsalicylic acid after discharge; treatment with statin
was started, with maintenance of anti-hypertensive drugs.
He initiated a smoking cessation intervention program in
the Pneumology outpatient clinic and started nicotine
replacement with nicotine gums.
What is noticeable is that there was neither endocarditis
nor any other foci of metastatic infection, and the mycotic
aneurysm was the only complication.
In the follow up there was no recurrence of the infectious
process and no acute ischemia of the limb, in spite of
some claudication complaints. Cilostazol, with antiplate-
let and vasodilating properties, indicated for symptomatic
relief in cases of intermittent claudication, isn't commer-
cially available in our country.
Notwithstanding medical advice, the patient maintains
smoking habits, which can contribute to worsening of his
peripheral arterial disease (PAD); smoking cessation is
critical for delaying the progression of PAD, and also to
reduce cardiovascular morbidity and mortality.
Conclusion
Infected femoral aneurysms constitute a challenging
problem in what concerns treatment options, as they are
associated with high mortality and morbidity, including
limb loss. A high index of suspicion should be present in
our minds whenever an inflammatory mass appears near
a large artery, so that prompt treatment is initiated.
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